Quels facteurs de risque influencent les niveaux de microARN ?
L'alimentation, le tabagisme et l'exposition à des toxines peuvent affecter les niveaux de microARN.
Facteurs de risqueMicroARNTabagisme
#2
Les maladies génétiques affectent-elles les microARN ?
Oui, certaines maladies génétiques peuvent altérer l'expression des microARN dans l'organisme.
Maladies génétiquesMicroARNExpression génique
#3
Le stress influence-t-il les microARN circulants ?
Des études montrent que le stress peut modifier l'expression des microARN dans le sang.
StressMicroARNFacteurs de risque
#4
L'âge affecte-t-il les niveaux de microARN ?
Oui, le vieillissement peut entraîner des changements dans l'expression des microARN circulants.
VieillissementMicroARNFacteurs de risque
#5
Les infections influencent-elles les microARN ?
Certaines infections peuvent altérer les niveaux de microARN, affectant la réponse immunitaire.
InfectionsMicroARNRéponse immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "MicroARN circulant : Questions médicales les plus fréquentes",
"headline": "MicroARN circulant : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les MicroARN circulant : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-12",
"dateModified": "2026-01-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "MicroARN circulant"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "microARN",
"url": "https://questionsmedicales.fr/mesh/D035683",
"about": {
"@type": "MedicalCondition",
"name": "microARN",
"code": {
"@type": "MedicalCode",
"code": "D035683",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.444.735.790.552.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "MicroARN circulant",
"alternateName": "Circulating MicroRNA",
"code": {
"@type": "MedicalCode",
"code": "D000074166",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Juntaro Matsuzaki",
"url": "https://questionsmedicales.fr/author/Juntaro%20Matsuzaki",
"affiliation": {
"@type": "Organization",
"name": "Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Takahiro Ochiya",
"url": "https://questionsmedicales.fr/author/Takahiro%20Ochiya",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular and Cellular Medicine, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan."
}
},
{
"@type": "Person",
"name": "Tetiana Pozniak",
"url": "https://questionsmedicales.fr/author/Tetiana%20Pozniak",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biophysics and Cell Engineering of the National Academy of Sciences of Belarus, 220072 Minsk, Belarus."
}
},
{
"@type": "Person",
"name": "Dzmitry Shcharbin",
"url": "https://questionsmedicales.fr/author/Dzmitry%20Shcharbin",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biophysics and Cell Engineering of the National Academy of Sciences of Belarus, 220072 Minsk, Belarus."
}
},
{
"@type": "Person",
"name": "Maria Bryszewska",
"url": "https://questionsmedicales.fr/author/Maria%20Bryszewska",
"affiliation": {
"@type": "Organization",
"name": "Department of General Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, 90-236 Lodz, Poland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Circulating MicroRNAs as Biomarker for Vessel-Associated Retinal Diseases.",
"datePublished": "2023-08-09",
"url": "https://questionsmedicales.fr/article/37721532",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000533481"
}
},
{
"@type": "ScholarlyArticle",
"name": "Serum-Circulating microRNAs in Sporadic Inclusion Body Myositis.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37446317",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241311139"
}
},
{
"@type": "ScholarlyArticle",
"name": "Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.",
"datePublished": "2023-08-28",
"url": "https://questionsmedicales.fr/article/37686149",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241713340"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smoking-related dysregulation of plasma circulating microRNAs: the Rotterdam study.",
"datePublished": "2023-07-10",
"url": "https://questionsmedicales.fr/article/37430296",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s40246-023-00504-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Circulating microRNAs predict recurrence and death following venous thromboembolism.",
"datePublished": "2023-07-20",
"url": "https://questionsmedicales.fr/article/37481073",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jtha.2023.07.010"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides nucléiques",
"item": "https://questionsmedicales.fr/mesh/D009696"
},
{
"@type": "ListItem",
"position": 4,
"name": "ARN",
"item": "https://questionsmedicales.fr/mesh/D012313"
},
{
"@type": "ListItem",
"position": 5,
"name": "ARN non traduit",
"item": "https://questionsmedicales.fr/mesh/D022661"
},
{
"@type": "ListItem",
"position": 6,
"name": "Petit ARN non traduit",
"item": "https://questionsmedicales.fr/mesh/D058727"
},
{
"@type": "ListItem",
"position": 7,
"name": "microARN",
"item": "https://questionsmedicales.fr/mesh/D035683"
},
{
"@type": "ListItem",
"position": 8,
"name": "MicroARN circulant",
"item": "https://questionsmedicales.fr/mesh/D000074166"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : MicroARN circulant - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur MicroARN circulant",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur MicroARN circulant",
"description": "Comment les microARN circulants sont-ils utilisés dans le diagnostic ?\nQuels tests mesurent les microARN circulants ?\nLes microARN circulants peuvent-ils indiquer une maladie ?\nPeut-on détecter des infections via les microARN ?\nLes microARN circulants sont-ils fiables pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D000074166#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur MicroARN circulant",
"description": "Quels symptômes peuvent être associés aux microARN circulants ?\nLes microARN circulants sont-ils liés à des symptômes spécifiques ?\nComment les microARN affectent-ils la santé ?\nPeut-on prédire des symptômes avec des microARN ?\nLes microARN circulants sont-ils liés à la douleur ?",
"url": "https://questionsmedicales.fr/mesh/D000074166#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur MicroARN circulant",
"description": "Les microARN circulants peuvent-ils aider à la prévention des maladies ?\nComment les microARN sont-ils liés à un mode de vie sain ?\nPeut-on modifier les niveaux de microARN par l'alimentation ?\nLes microARN peuvent-ils être utilisés pour des dépistages préventifs ?\nQuels facteurs environnementaux influencent les microARN ?",
"url": "https://questionsmedicales.fr/mesh/D000074166#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur MicroARN circulant",
"description": "Les microARN circulants peuvent-ils être ciblés par des traitements ?\nQuels traitements utilisent les microARN ?\nLes microARN peuvent-ils être utilisés en médecine régénérative ?\nLes traitements basés sur les microARN sont-ils sûrs ?\nComment les microARN influencent-ils les traitements ?",
"url": "https://questionsmedicales.fr/mesh/D000074166#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur MicroARN circulant",
"description": "Quelles complications peuvent survenir avec des niveaux anormaux de microARN ?\nLes microARN circulants sont-ils impliqués dans des maladies chroniques ?\nComment les microARN affectent-ils le pronostic des maladies ?\nLes microARN peuvent-ils causer des complications post-opératoires ?\nLes microARN sont-ils liés à des complications neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D000074166#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur MicroARN circulant",
"description": "Quels facteurs de risque influencent les niveaux de microARN ?\nLes maladies génétiques affectent-elles les microARN ?\nLe stress influence-t-il les microARN circulants ?\nL'âge affecte-t-il les niveaux de microARN ?\nLes infections influencent-elles les microARN ?",
"url": "https://questionsmedicales.fr/mesh/D000074166#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les microARN circulants sont-ils utilisés dans le diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils servent de biomarqueurs pour détecter certaines maladies, comme le cancer."
}
},
{
"@type": "Question",
"name": "Quels tests mesurent les microARN circulants ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests PCR et des analyses de séquençage sont utilisés pour quantifier les microARN."
}
},
{
"@type": "Question",
"name": "Les microARN circulants peuvent-ils indiquer une maladie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux anormaux de microARN peuvent signaler des pathologies comme le cancer."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des infections via les microARN ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études montrent que les microARN peuvent indiquer des infections virales."
}
},
{
"@type": "Question",
"name": "Les microARN circulants sont-ils fiables pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils montrent un potentiel prometteur, mais des recherches supplémentaires sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent être associés aux microARN circulants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les microARN eux-mêmes ne causent pas de symptômes, mais leur dysrégulation peut indiquer des maladies."
}
},
{
"@type": "Question",
"name": "Les microARN circulants sont-ils liés à des symptômes spécifiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être associés à des symptômes de maladies comme le cancer ou les maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment les microARN affectent-ils la santé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils régulent l'expression génique, influençant ainsi divers processus biologiques et pathologiques."
}
},
{
"@type": "Question",
"name": "Peut-on prédire des symptômes avec des microARN ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent qu'ils pourraient aider à prédire l'évolution de certaines maladies."
}
},
{
"@type": "Question",
"name": "Les microARN circulants sont-ils liés à la douleur ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches explorent leur rôle dans la modulation de la douleur, mais les résultats sont préliminaires."
}
},
{
"@type": "Question",
"name": "Les microARN circulants peuvent-ils aider à la prévention des maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en identifiant des biomarqueurs, ils peuvent aider à détecter des maladies précocement."
}
},
{
"@type": "Question",
"name": "Comment les microARN sont-ils liés à un mode de vie sain ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut influencer l'expression des microARN, réduisant le risque de maladies."
}
},
{
"@type": "Question",
"name": "Peut-on modifier les niveaux de microARN par l'alimentation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que des aliments spécifiques peuvent influencer les niveaux de microARN."
}
},
{
"@type": "Question",
"name": "Les microARN peuvent-ils être utilisés pour des dépistages préventifs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, leur mesure pourrait devenir un outil de dépistage pour certaines maladies comme le cancer."
}
},
{
"@type": "Question",
"name": "Quels facteurs environnementaux influencent les microARN ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pollution, le tabagisme et d'autres facteurs environnementaux peuvent affecter leur expression."
}
},
{
"@type": "Question",
"name": "Les microARN circulants peuvent-ils être ciblés par des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thérapies ciblant les microARN sont en développement pour traiter diverses maladies."
}
},
{
"@type": "Question",
"name": "Quels traitements utilisent les microARN ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements expérimentaux incluent des inhibiteurs de microARN pour le cancer et d'autres maladies."
}
},
{
"@type": "Question",
"name": "Les microARN peuvent-ils être utilisés en médecine régénérative ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont étudiés pour leur potentiel à régénérer des tissus et à réparer des organes."
}
},
{
"@type": "Question",
"name": "Les traitements basés sur les microARN sont-ils sûrs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La sécurité est encore à évaluer, mais des essais cliniques sont en cours pour déterminer leur efficacité."
}
},
{
"@type": "Question",
"name": "Comment les microARN influencent-ils les traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent moduler la réponse aux traitements en régulant des gènes impliqués dans la résistance."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des niveaux anormaux de microARN ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des niveaux anormaux peuvent être associés à des maladies graves comme le cancer ou des maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les microARN circulants sont-ils impliqués dans des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont liés à des maladies chroniques comme le diabète et les maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment les microARN affectent-ils le pronostic des maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des profils de microARN peuvent prédire l'évolution et le pronostic de certaines maladies."
}
},
{
"@type": "Question",
"name": "Les microARN peuvent-ils causer des complications post-opératoires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études explorent leur rôle dans la cicatrisation et les complications après chirurgie."
}
},
{
"@type": "Question",
"name": "Les microARN sont-ils liés à des complications neurologiques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des recherches montrent qu'ils peuvent être impliqués dans des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent les niveaux de microARN ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'alimentation, le tabagisme et l'exposition à des toxines peuvent affecter les niveaux de microARN."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques affectent-elles les microARN ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques peuvent altérer l'expression des microARN dans l'organisme."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les microARN circulants ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que le stress peut modifier l'expression des microARN dans le sang."
}
},
{
"@type": "Question",
"name": "L'âge affecte-t-il les niveaux de microARN ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut entraîner des changements dans l'expression des microARN circulants."
}
},
{
"@type": "Question",
"name": "Les infections influencent-elles les microARN ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent altérer les niveaux de microARN, affectant la réponse immunitaire."
}
}
]
}
]
}
Department of Surgery, Osaka Police Hospital, 10-31 Kitayama-cho, Tennouji-ku, Osaka 543-0035, Japan.
Department of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Yamadaoka 1-7, Suita, Osaka 565-0871, Japan.
Department of Molecular Pathology, Division of Health Sciences, Graduate School of Medicine, Osaka University, Yamadaoka 1-7, Suita, Osaka 565-0871, Japan.
Vessel-associated retinal diseases are a major cause of blindness and severe visual impairment. The identification of appropriate biomarkers is of great importance to better anticipate disease progres...
Relative quantification by quantitative real-time polymerase chain reaction was used to analyze miRNA expression in patients with vessel-associated retinal diseases such as age-related macular degener...
In serum samples, miR-29a-3p and miR-192-5p showed increased expression in patients with neovascular AMD relative to control patients. Similarly, miR-335-5p, miR-192-5p, and miR-194-5p showed increase...
The miRNAs investigated in this study may have the potential to serve as biomarkers for vessel-associated retinal diseases. Combining multiple miRNAs may enhance the predictive power of the analysis....
Sporadic inclusion body myositis (s-IBM) represents a unique disease within idiopathic inflammatory myopathies with a dual myodegenerative-autoimmune physiopathology and a lack of an efficacious treat...
There is an urgent unmet need for robust and reliable biomarkers for early diagnosis, prognosis, and prediction of response to specific treatments of many aggressive and deadly cancers, such as pancre...
MicroRNAs (miRNAs) are post-transcriptional regulators of gene expression. Differential miRNA expression, which is widely shown to be associated with the pathogenesis of various diseases, can be influ...
A targeted RNA-sequencing approach measured plasma miRNA levels in 2686 participants from the population-based Rotterdam study cohort. The association between cigarette smoking (current versus never) ...
This study demonstrates smoking-related dysregulation of plasma miRNAs, which might have a potential for reversibility when comparing different smoking cessation groups. The identified miRNAs are invo...
Recurrent events frequently occur after venous thromboembolism (VTE) and remain difficult to predict based on established genetic, clinical, and proteomic contributors. The role of circulating microRN...
To identify circulating miRNAs predictive of recurrent VTE or death, and to interpret their mechanistic involvement....
Data from 181 participants of a cohort study of acute VTE and 302 individuals with a history of VTE from a population-based cohort were investigated. Next-generation sequencing was performed on EDTA p...
A total of 1950 miRNAs were detected across cohorts after postprocessing. In the discovery cohort, 50 miRNAs were associated with recurrent VTE or death (cross-validated C-index, 0.65). A weighted miR...
Circulating miRNAs predicted the risk of recurrence or death after VTE over several years, both in the acute and chronic phases....
miR-122 is the most abundant microRNA (miRNA) in the liver; it regulates several genes mainly involved in cell metabolism and inflammation. Host factors, diet, metabolic disorders and viral infection ...
MicroRNAs (miRs) are small noncoding RNAs that regulate gene expression and are emerging as powerful indicators of diseases. MiRs are secreted in blood plasma and thus may report on systemic aberratio...
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy. Pathogenic germline variation in genes encoding the sarcomere is the predominant cause of disease. However diagnostic featu...
We performed arrays for 381 miRNAs using serum from HCM sarcomere variant carriers with and without a diagnosis of HCM and healthy controls. To identify differentially expressed circulating miRNAs bet...
Of 57 sarcomere variant carriers, 25 had clinical HCM and 32 had subclinical HCM with normal left ventricular wall thickness (21 with early phenotypic manifestations and 11 with no discernible phenoty...
Circulating miRNAs may augment the clinical stratification of HCM and improve understanding of the transition from health to disease in sarcomere gene variant carriers....
MicroRNAs (miR) have altered expression in multiple autoimmune disorders including inflammatory bowel disease. The aim of the study was to assess the tissue and circulating miR-31, miR-200b, and miR-2...
The study included 45 patients with histopathological confirmed CD and active disease (defined as fecal calprotectin >50 μg/g and Simple Endoscopic Score (SES) of CD >3), and 21 subjects as controls f...
Mean fecal calprotectin was 1540±890 μg/g. Mean SES-CD was 8.9±4.2. Tissue and circulating miR- 31 were significantly correlated with fecal calprotectin (r=0.81, r=0.83, p<0.01) and with SES-CD (r=0.8...
Tissue and circulating miR-31, miR-200b, and miR-200c reflect disease activity in CD patients and can be used as biomarkers for active disease....
Circulating microRNAs have been implicated in a diverse array of biological and pathological phenomena. Their potential utility as noninvasive biomarkers for screening and diagnosing various diseases ...
This study aimed to explore the potential role of the miRNAs miR-122 and miR-486 as molecular biomarkers in the pathogenesis of hepatitis C virus (HCV) infection. Thus, miR-122 and miR-486 were detect...
A total of 150 subjects aged 30 to 66 years were included in this study. The patients were classified as patients with chronic hepatitis C virus (CHC) (n = 110) or healthy controls (n = 40). Real-time...
Compared with those in normal controls, significant increases in the serum levels of miR-122 and miR-486 were reported in patients with CHC. In physically active CHC patients, there was a significant ...
MiR-122 and miR-486 expression levels were strongly correlated with physical activity, pain perception, and muscle fatigue biomarkers in HCV-infected patients. These miRNA levels were associated with ...